JP Morgan Chase
GOCO

JP Morgan Chase’s GoHealth GOCO Stock Holding History

JP Morgan Chase’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,311
Closed -$32.6K – 7871
2026
Q1 		$32.6K Buy
21,311
+12,525
+143% +$23.9K ﹤0.01% 6366
2025
Q4 		$18.9K Buy
8,786
+5,862
+200% +$20K ﹤0.01% 6522
2025
Q3 		$14.1K Buy
2,924
+575
+24% +$3.14K ﹤0.01% 6565
2025
Q2 		$13K Sell
2,349
-2,426
-51% -$19.2K ﹤0.01% 6265
2025
Q1 		$58.6K Sell
4,775
-12,420
-72% -$190K ﹤0.01% 5823
2024
Q4 		$230K Buy
17,195
+8,758
+104% +$99.6K ﹤0.01% 5418
2024
Q3 		$79.1K Buy
8,437
+4,204
+99% +$42.6K ﹤0.01% 5796
2024
Q2 		$41.1K Sell
4,233
-4,593
-52% -$45.4K ﹤0.01% 5934
2024
Q1 		$92.8K Buy
8,826
+3,774
+75% +$46.7K ﹤0.01% 5704
2023
Q4 		$67.4K Buy
5,052
+2,509
+99% +$34.3K ﹤0.01% 5898
2023
Q3 		$36.8K Sell
2,543
-584
-19% -$10.1K ﹤0.01% 5899
2023
Q2 		$61.6K Buy
3,127
+3,125
+156,250% +$49.1K ﹤0.01% 5661
2023
Q1 		$0 Hold
2
– – ﹤0.01% 6910
2022
Q4 		$0 Sell
2
-1
-33% -$9 ﹤0.01% 6722
2022
Q3 		$0 Hold
3
– – ﹤0.01% 6606
2022
Q2 		$0 Sell
3
-12
-80% -$140 ﹤0.01% 6629
2022
Q1 		$0 Sell
15
-341
-96% -$10.6K ﹤0.01% 6759
2021
Q4 		$20K Sell
356
-649
-65% -$43.3K ﹤0.01% 6218
2021
Q3 		$76K Sell
1,005
-4,790
-83% -$507K ﹤0.01% 5701
2021
Q2 		$974K Buy
5,795
+425
+8% +$74.4K ﹤0.01% 4315
2021
Q1 		$942K Buy
5,370
+5,352
+29,733% +$1.08M ﹤0.01% 4278
2020
Q4 		$4K Buy
+18
New +$3.34K ﹤0.01% 5465

Other funds holding GOCO

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's GOCO Position: Q2 2026 in Review

JP Morgan Chase sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 21,311 shares — an estimated $32.6K sold.

JP Morgan Chase first reported a position in GOCO in Q4 2020 and held it in 22 quarters. The position peaked at $974K in Q2 2021. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • JP Morgan Chase reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 21,311 GoHealth shares in Q2 2026, an estimated $32.6K.
  • JP Morgan Chase first reported a position in GoHealth in Q4 2020 and held it in 22 quarters.
  • JP Morgan Chase's GoHealth position peaked at $974K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.